News
2020
-
Holdings
Investors
October 29, 2020
-
The 2nd Quarter of Fiscal 2020 Financial Statements
-
Holdings
Investors
October 29, 2020
-
Reference Data
-
Holdings
Corporate
August 31, 2020
-
Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. on the Distribution of Prescription Drugs of Biofermin Pharmaceutical Co., Ltd.
-
Holdings
Investors
August 6, 2020
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Corporate
June 26, 2020
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Investors
May 14, 2020
-
Financial Statements for Fiscal 2019
-
Holdings
Investors
May 14, 2020
-
Reference Data
-
Group Company
R&D
April 30, 2020
-
Taisho and BioAge sign exclusive license agreement for the development, manufacturing, and commercialization of hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, TS-143, worldwide
-
Holdings
Investors
February 14, 2020
-
Financial Statements for the 3rd Quarter of Fiscal 2019
-
Holdings
Investors
February 14, 2020
-
Reference Data
-
Holdings
Investors
February 14, 2020
-
Notice of Revision of Forecasts for the Fiscal Year Ending March 31, 2020
-
Holdings
Investors
January 30, 2020
-
Notice of Postponement of Announcement of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020